Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Nov;122(11):2155-6.
doi: 10.1016/j.ophtha.2015.08.007.

Should We Add Screening of Age-Related Macular Degeneration to Current Screening Programs for Diabetic Retinopathy?

Emily Y Chew  1 , Andrew P Schachat  2
Affiliations
Editorial

Should We Add Screening of Age-Related Macular Degeneration to Current Screening Programs for Diabetic Retinopathy?

Emily Y Chew et al. Ophthalmology. 2015 Nov.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Chan CK, Gangwani RA, McGhee SM, et al. Cost-effectiveness of screening for intermediate age-related macular degeneration during diabetic retinopathy screening. Ophthalmology 2015;122:2278–85. - PubMed
    1. Whited JD, Datta SK, Aiello LM, et al. A modeled economic analysis of a digital tele-ophthalmology system as used by three federal health care agencies for detecting proliferative diabetic retinopathy. Telemed J E Health 2005;11:641–51. - PubMed
    1. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996;124:164–9. - PubMed
    1. Ferris FL 3rd. How effective are treatments for diabetic retinopathy? JAMA 1993;269:1290–1. - PubMed
    1. The Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report no. 8. Arch Ophthalmol 2001;119:1417–36. - PMC - PubMed